OverviewChartNewsTraderScreen

BVT Call 360 AMGN 21.06.2024/  DE000VM9PR41  /

EUWAX
13/05/2024  08:48:05 Chg.-0.012 Bid22:00:05 Ask22:00:05 Underlying Strike price Expiration date Option type
0.012EUR -50.00% -
Bid Size: -		 -
Ask Size: -		 Amgen Inc 360.00 USD 21/06/2024 Call
GlobeNewswire 13/05 TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 09/05 Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan
GlobeNewswire 09/05 argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 CytomX Therapeutics Announces Positive Initial Phase 1a Dose Escalation Data for Monotherapy CX-904 ...
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
TeleTrader 08/05 US closes flat to higher with more earnings on the horizon
GlobeNewswire 08/05 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
TeleTrader 03/05 US closes higher after softer-than-expected jobs print
TeleTrader 03/05 Wall Street surges on open as jobs report sparks rate cut hopes
TeleTrader 03/05 Amgen soars 14% on positive weight-loss drug data
TeleTrader 02/05 Amgen Q1 revenue jumps 22% to $7.4 billion
TeleTrader 02/05 US surges at close as traders weigh Fed remarks
TeleTrader 02/05 US opens higher, Dow jumps 240 points
GlobeNewswire 02/05 Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 02/05 US higher premarket after Fed's decision
GlobeNewswire 01/05 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 30/04 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 24/04 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
TeleTrader 24/04 Wall Street opens mostly higher amid earnings jitters
GlobeNewswire 23/04 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 16/04 Turnstone Biologics Appoints William Waddill to its Board of Directors
GlobeNewswire 15/04 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 15/04 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer